🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Longitudinal Body Composition Assessment in Breast Cancer Patients

Recruitingn/aAges 18 Years - anyFemaleTaipei Tzu Chi Hospital, Buddhist Tzu Chi Medical…
NCT07472803 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This observational cohort study aims to track longitudinal changes in body composition, including skeletal muscle mass and fat distribution, in patients diagnosed with breast cancer. Following primary surgery and adjuvant therapy, participants will be monitored over a 2-year period. The primary objective is to evaluate the natural progression of skeletal muscle mass index (SMI) and metabolic changes in this population. By conducting serial measurements, this study seeks to characterize the longitudinal trends in muscle loss and body composition shifts post-treatment, providing data to better understand the physiological impact of the cancer recovery process.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * \>18 years of age * Diagnosed with stage I-III non-metastatic breast cancer within 12 months of diagnosis * Scheduled for surgery, chemotherapy, with or without radiotherapy or targeted therapy. Exclusion Criteria: * Women diagnosed with metastatic (stage IV) breast cancer * Women planning to move away from the area or be away for more than 6 months during the study period * Women planning to become pregnant during the study period * Implantable devices (e.g., pacemaker, nerve stimulator) or surgical implants (e.g., total hip or knee replacements)
💊

What it tests

  • Not listed
📍

Where

1 site
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
New Taipei City, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy